C4 Therapeutics Inc (NASDAQ: CCCC): Reassessing Prospects
C4 Therapeutics Inc (CCCC) concluded trading on Thursady at a closing price of $8.80, with 6.9 million shares of worth about $60.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 170.77% during that period and on Thursady the price saw a gain of […]
C4 Therapeutics Inc (CCCC) Outlook Starting To Look Brighter?
C4 Therapeutics Inc (CCCC) concluded trading on Thursday at a closing price of $7.90, with 4.14 million shares of worth about $32.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 138.67% during that period and on Thursday the price saw a gain of […]
Reassessing The Changing Outlook For C4 Therapeutics Inc (CCCC)
Currently, there are 48.97M common shares owned by the public and among those 38.33M shares have been available to trade. Insiders at the company have transacted a total of 44 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 31 of these insider trades were purchases, […]
C4 Therapeutics Inc (NASDAQ: CCCC) Stock In Prove Me State
C4 Therapeutics Inc (CCCC) concluded trading on Wednesday at a closing price of $5.55, with 4.15 million shares of worth about $23.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 48.00% during that period and On Wednesday, January 24 the price saw a […]
C4 Therapeutics Inc (CCCC) Testing Investors’ Patience Right Now
RA Capital Management LP recently announced the acquisition of new stake in C4 Therapeutics Inc (NASDAQ:CCCC). This fresh investment now brings its stake to 9.90% valued currently at $7.95 million. In addition, Commodore Capital LP raised its holdings by 3.8 million to 3.8 million shares. And Lynx1 Capital Management LP has lifted its position by […]
C4 Therapeutics Inc (CCCC): Street Finally Waking Up
RA Capital Management LP recently announced the acquisition of new stake in C4 Therapeutics Inc (NASDAQ:CCCC). This fresh investment now brings its stake to 9.90% valued currently at $7.95 million. In addition, Commodore Capital LP raised its holdings by 3.8 million to 3.8 million shares. And Lynx1 Capital Management LP has lifted its position by […]
Reviewing The Case For C4 Therapeutics Inc (CCCC) Going Higher
Lynx1 Capital Management LP recently announced the acquisition of new stake in C4 Therapeutics Inc (NASDAQ:CCCC). The institutional investor has increased its shareholding in the Healthcare company by 206.33% to 3.12 million shares with purchase of 2.1 million shares. This fresh investment now brings its stake to 6.34% valued currently at $5.09 million. In addition, […]
C4 Therapeutics Inc (NASDAQ: CCCC) Hogging The Spotlight Today
Lynx1 Capital Management LP recently announced the acquisition of new stake in C4 Therapeutics Inc (NASDAQ:CCCC). The institutional investor has increased its shareholding in the Healthcare company by 206.33% to 3.12 million shares with purchase of 2.1 million shares. This fresh investment now brings its stake to 6.34% valued currently at $5.09 million. In addition, […]
